Daily archive

May 23, 2018


Should You Buy Endocyte, Inc (NASDAQ: ECYT) at $14.29?

By Matt Hogan

Shares of Endocyte, Inc (NASDAQ: ECYT) are receiving a lot of investor interest as of late due to the stock’s 300.3% increase over the prior three months. Shareholders are now asking themselves whether the company’s current stock price is reflective of its true value or if shares have even further upside from here. Let’s take a look… Keep Reading


Why Activision Blizzard, Inc’s (NASDAQ: ATVI) Dividend Potential Should Concern Investors

By Andy Pai

Activision Blizzard, Inc (NASDAQ: ATVI) is currently paying investors a below average dividend yield of 0.5% while the Information Technology sector median stands at 1.7%. Even though this makes Activision Blizzard look uninviting relative to its peers, it’s useful to understand the company’s future dividend potential. Will Activision Blizzard’s bottom line be the main catalyst driving… Keep Reading


Is Medtronic PLC (NYSE: MDT) Management Utilizing Shareholder’s Equity Efficiently?

By Brian Dentino

Medtronic PLC (NYSE: MDT) generated an outstanding return on equity of 5.6% over the past twelve months, while the Healthcare sector returned -35.1%. Even though Medtronic’s performance is highly impressive relative to its peers, it’s useful to understand what’s really driving the company’s strong ROE and how it’s trending. Understanding these components may change your views… Keep Reading

Go to Top